Elevated Plasma Concentrations of Atrial and Brain Natriuretic Peptide in Type 1 Diabetic Subjects

Overview

Journal Ir J Med Sci

Specialty General Medicine

Date 2005 Nov 16

PMID 16285340

Citations 3

Authors

K McKenna

D Smith

M Sherlock

K Moore

E OBrien

W Tormey

C J Thompson

Affiliations

Soon will be listed here.

Abstract

Background: The intravenous infusion of atrial (ANP) and brain (BNP) natriuretic peptides have been shown to increase urinary albumin excretion in type 1 diabetes.

Aims: To measure plasma ANP and BNP concentrations in patients with type 1 diabetes and to examine the parameters associated with elevated plasma concentrations. Methods We measured plasma ANP and BNP concentrations, UAER, HbA1C systolic blood pressure, and left ventricular mass index. Plasma ANP and BNP were also measured in non-diabetic control subjects for comparison.

Results: Using multivariate regression analysis plasma ANP correlated positively with HbA1C (1.9 + 0.47, p = 0.0002), UAER (0.37 + 0.05, p = 0.00001), SBP (1.26 + 0.5, p = 0.01) and LVMI (00.46 + 0.25, p = 0.07). BNP was positively related with LVMI (0.95 + 0.4, p = 0.02), and UAER (0.56 + 0.08, p = 0.001).

Conclusions: Plasma concentrations of ANP and BNP are elevated in some patients with type 1 diabetes. Plasma ANP concentrations are closely related to UAER and elevated plasma concentrations are associated with poor glycaemic control and systemic hypertension. Plasma BNP concentration is related to LVMI.

Citing Articles

A State of Natriuretic Peptide Deficiency.

Nyberg M, Terzic D, Ludvigsen T, Mark P, Michaelsen N, Abildstrom S Endocr Rev. 2022; 44(3):379-392.

PMID: 36346821 PMC: 10166265. DOI: 10.1210/endrev/bnac029.

Cardiovascular biomarkers in pregnancy with diabetes and associations to glucose control.

Jacobsen D, Roysland R, Strand H, Moe K, Sugulle M, Omland T Acta Diabetol. 2022; 59(9):1229-1236.

PMID: 35796791 PMC: 9329411. DOI: 10.1007/s00592-022-01916-w.

Blood pressure lowering for the prevention and treatment of diabetic kidney disease.

Thomas M, Atkins R Drugs. 2006; 66(17):2213-34.

PMID: 17137404 DOI: 10.2165/00003495-200666170-00005.

References

Kohno M, Horio T, Yokokawa K, Murakawa K, Yasunari K, Akioka K . Brain natriuretic peptide as a cardiac hormone in essential hypertension. Am J Med. 1992; 92(1):29-34. DOI: 10.1016/0002-9343(92)90011-y. View

McKenna K, Smith D, Tormey W, Thompson C . Acute hyperglycaemia causes elevation in plasma atrial natriuretic peptide concentrations in Type 1 diabetes mellitus. Diabet Med. 2000; 17(7):512-7. DOI: 10.1046/j.1464-5491.2000.00318.x. View

Tanabe A, Naruse M, Wasada T, Naruse K, Yoshimoto T, Omori Y . Effects of acute hyperinsulinemia on plasma atrial and brain natriuretic peptide concentrations. Eur J Endocrinol. 1995; 132(6):693-8. DOI: 10.1530/eje.0.1320693. View

Yandle T, Richards A, Gilbert A, Fisher S, Holmes S, Espiner E . Assay of brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failure. J Clin Endocrinol Metab. 1993; 76(4):832-8. DOI: 10.1210/jcem.76.4.8473392. View

McKnight J, Roberts G, Sheridan B, Bell P, Atkinson A . Basal and stimulated plasma atrial natriuretic factor in patients with type 1 diabetes with and without nephropathy. Diabet Med. 1991; 8(8):765-9. DOI: 10.1111/j.1464-5491.1991.tb01697.x. View

Sawicki P, Heinemann L, Rave K, Hohmann A, Berger M . Atrial natriuretic factor in various stages of diabetic nephropathy. J Diabet Complications. 1988; 2(4):207-9. DOI: 10.1016/s0891-6632(88)80010-2. View

Bell G, Bernstein R, LARAGH J, Atlas S, James G, Pecker M . Increased plasma atrial natriuretic factor and reduced plasma renin in patients with poorly controlled diabetes mellitus. Clin Sci (Lond). 1989; 77(2):177-82. DOI: 10.1042/cs0770177. View

Totsune K, Takahashi K, Satoh F, Sone M, Ohneda M, SATOH C . Urinary immunoreactive brain natriuretic peptide in patients with renal disease. Regul Pept. 1996; 63(2-3):141-7. DOI: 10.1016/0167-0115(96)00035-3. View

McKenna K, Smith D, Barrett P, Glenn A, KESSON C, Connell J . Angiotensin-converting enzyme inhibition by quinapril blocks the albuminuric effect of atrial natriuretic peptide in Type 1 diabetes and microalbuminuria. Diabet Med. 2000; 17(3):219-24. DOI: 10.1046/j.1464-5491.2000.00255.x. View

10.

Zietse R, Derkx F, Weimar W, SCHALEKAMP M . Effect of atrial natriuretic peptide on renal and vascular permeability in diabetes mellitus. J Am Soc Nephrol. 1995; 5(12):2057-66. DOI: 10.1681/ASN.V5122057. View

11.

JACOBS E, Vervoort G, Branten A, Klasen I, Smits P, Wetzels J . Atrial natriuretic peptide increases albuminuria in type I diabetic patients: evidence for blockade of tubular protein reabsorption. Eur J Clin Invest. 1999; 29(2):109-15. DOI: 10.1046/j.1365-2362.1999.00422.x. View

12.

Florkowski C, Richards A, Espiner E, Yandle T, Frampton C . Renal, endocrine, and hemodynamic interactions of atrial and brain natriuretic peptides in normal men. Am J Physiol. 1994; 266(4 Pt 2):R1244-50. DOI: 10.1152/ajpregu.1994.266.4.R1244. View

13.

Kambayashi Y, Nakao K, Mukoyama M, Saito Y, Ogawa Y, Shiono S . Isolation and sequence determination of human brain natriuretic peptide in human atrium. FEBS Lett. 1990; 259(2):341-5. DOI: 10.1016/0014-5793(90)80043-i. View

14.

Prasad N, Clarkson P, MacDonald T, Ryan M, Struthers A, Thompson C . Atrial natriuretic peptide increases urinary albumin excretion in men with type 1 diabetes mellitus and established microalbuminuria. Diabet Med. 1998; 15(8):678-82. DOI: 10.1002/(SICI)1096-9136(199808)15:8<678::AID-DIA639>3.0.CO;2-K. View

15.

Ortola F, Ballermann B, Anderson S, Mendez R, Brenner B . Elevated plasma atrial natriuretic peptide levels in diabetic rats. Potential mediator of hyperfiltration. J Clin Invest. 1987; 80(3):670-4. PMC: 442289. DOI: 10.1172/JCI113120. View

16.

Ferri C, Piccoli A, Laurenti O, Bellini C, De Mattia G, Santucci A . Atrial natriuretic factor in hypertensive and normotensive diabetic patients. Diabetes Care. 1994; 17(3):195-200. DOI: 10.2337/diacare.17.3.195. View

17.

Trevisan R, Fioretto P, Semplicini A, Opocher G, Mantero F, Rocco S . Role of insulin and atrial natriuretic peptide in sodium retention in insulin-treated IDDM patients during isotonic volume expansion. Diabetes. 1990; 39(3):289-98. DOI: 10.2337/diab.39.3.289. View

18.

McKenna K, Smith D, Moore K, Glen A, Tormey W, Thompson C . Brain natriuretic peptide increases urinary albumin and alpha-1 microglobulin excretion in Type 1 diabetes mellitus. Diabet Med. 2002; 18(12):973-8. DOI: 10.1046/j.0742-3071.2001.00569.x. View

19.

McKenna K, Smith D, Moore K, Glen A, KESSON C, Thompson C . Enhanced albuminuric response to atrial natriuretic peptide in normoalbuminuric patients with Type 1 diabetes mellitus--a pilot study. Diabet Med. 2000; 17(6):463-8. DOI: 10.1046/j.1464-5491.2000.00303.x. View

20.

Chan J, Cheung C, Cockram C, Critchley J, Swaminathan R, Law L . Atrial natriuretic peptide and renin-angiotensin-aldosterone system in non-insulin-dependent diabetes mellitus. J Hum Hypertens. 1994; 8(6):451-6. View